ATRIのチャート
ATRIの企業情報
| symbol | ATRI |
|---|---|
| 会社名 | Atrion Corp. （アトリオン） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 アトリオン(Atrion Corporation)は主に医療用アプリケーション向けの製品を開発・製造する企業である。同社の医療製品は、液体送達デバイスから眼科用および心血管用製品までにわたる。その液体配送製品には、感染制御と針の安全性を促進するバルブが含まれている。麻酔と腫瘍学などの分野で、多様な挿管、静脈内、カテーテル、およびその他の用途に使用するために、制御された量の液体または気体を必要に応じて充填・保持・放出するように設計された一連の弁を開発した。その心臓血管製品であるMPS2心筋保護システム（MPS2）は、心臓外科手術に使用され、体液と薬物を送達し、重要な薬物を混合し、温度、圧力および他の変数を制御するシステムである。同社はコンタクトレンズを消毒する特殊医療機器を製造している。その他の医療用・非医療用の製品ラインは、計装および関連する使い捨て品で構成されている。 アトリオンは、主に医療用途製品の米国メ―カ―。医療製品は、流体送達デバイスから眼科や心臓血管の製品を開発・製造する。流体送達製品は、感染対策及び針の安全性を促進する弁、眼科用製品は、コンタクトレンズの消毒ケ―スと、鼻涙管閉塞の治療に使用されるバル―ンカテ―テルが含まれる。 Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. As a developer and manufacturer of a diverse range of products, Atrion stays on the forefront of technology and manufacturing with products that meet the needs of its targeted markets. |
| 本社所在地 | One Allentown Parkway Allen TX 75002 USA |
| 代表者氏名 | Emile A. Battat エミールA.バタット |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 972-390-9800 |
| 設立年月日 | 29952 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 528人 |
| url | www.atrioncorp.com |
| nasdaq_url | https://www.nasdaq.com/symbol/atri |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 51.31300 |
| 終値（lastsale） | 685.31 |
| 時価総額（marketcap） | 1269712214.36 |
| 時価総額 | 時価総額（百万ドル） 1268.137 |
| 売上高 | 売上高（百万ドル） 150.17500 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1207.898 |
| 当期純利益 | 当期純利益（百万ドル） 30.45700 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Atrion Corporation revenues increased 5% to $78.2M. Net income decreased 13% to $17.3M. Revenues reflect United States segment increase of 7% to $24.6M. Net income was offset by Other investment income/(losses) decrease from $1K (income) to $1.2M (expense) Selling increase of 12% to $4.1M (expense). Dividend per share increased from $2.10 to $2.40. |
ATRIのテクニカル分析
ATRIのニュース
Atrion declares $1.95 dividend 2022/05/24 22:02:54 Seeking Alpha
Atrion (NASDAQ:ATRI) declares $1.95/share quarterly dividend, in line with previous.Forward yield 1.25%Payable June 30; for shareholders of record June 15; ex-div June 14.See ATRI Dividend…
Atrion GAAP EPS of $4.71, revenue of $47.14M 2022/05/09 21:24:09 Seeking Alpha
Atrion press release (ATRI): Q1 GAAP EPS of $4.71.Revenue of $47.14M (+20.3% Y/Y).CEO comment: “The substantial expansion of one of our manufacturing facilities remains on track…
Atrion: Q1 Earnings Snapshot 2022/05/09 20:19:58 mySA
ALLEN, Texas (AP) _ Atrion Corp. (ATRI) on Monday reported first-quarter profit of $8.5 million. On a per-share basis, the Allen, Texas-based company said it had net income of $4.71. The medical device maker posted revenue of $47.1 million in the period. Atrion shares have declined 12% since the beginning of the year. In the final minutes of trading on Monday, shares hit $622.60, a drop of 0.5% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRI at https://www.zacks.com/ap/ATRI
Atrion Reports First Quarter 2022 Results 2022/05/09 20:00:00 GlobeNewswire
ALLEN, Texas, May 09, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2022.
Atrion: Q4 Earnings Snapshot 2022/02/25 21:08:55 mySA
ALLEN, Texas (AP) _ Atrion Corp. (ATRI) on Friday reported fourth-quarter net income of $8.1 million. The Allen, Texas-based company said it had profit of $4.50 per share. The medical device maker posted revenue of $40.3 million in the period. For the year, the company reported profit of $33.1 million, or $18.18 per share. Revenue was reported as $165 million. Atrion shares have dropped 1% since the beginning of the year. In the final minutes of trading on Friday, shares hit $696.48, a rise of roughly 9% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRI at https://www.zacks.com/ap/ATRI
Atrion Corporation Declares Quarterly Cash Dividend - Stocks News Feed 2021/02/26 19:50:00 Stocks News Feed
ALLEN, Texas, Feb. 26, 2021 (GLOBE NEWSWIRE) — Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.75 per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2021 to stockholders of record at the close of business on March 15,… Read More »Atrion Corporation Declares Quarterly Cash Dividend
Atrion Corporation Declares Quarterly Cash Dividend - Stocks News Feed 2020/11/13 21:30:00 Stocks News Feed
ALLEN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) — Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.75 per share on its outstanding shares of Common Stock. This dividend will be payable on December 15, 2020 to stockholders of record at the close of business on December 1,… Read More »Atrion Corporation Declares Quarterly Cash Dividend
Atrion Reports Third Quarter Results 2020/11/09 21:30:00 GlobeNewswire
ALLEN, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended September 30, 2020…
Atrion (NASDAQ:ATRI) Lifted to Sell at BidaskClub 2020/10/21 06:22:59 Transcript Daily
BidaskClub upgraded shares of Atrion (NASDAQ:ATRI) from a strong sell rating to a sell rating in a research report released on Saturday morning, BidAskClub reports. Shares of NASDAQ ATRI opened at $653.00 on Friday. The firm has a fifty day moving average price of $638.23 and a 200-day moving average price of $649.27. The stock […]
ATRI Trucking Nuclear Verdict Study Misleads, Misinforms, Says ATAA 2020/06/25 12:31:00 PR Newswire
WASHINGTON, June 25, 2020 /PRNewswire/ -- The just-released report from the American Transportation Research Institute (ATRI) claiming "nuclear verdicts" in the trucking industry require changes to the tort system is grossly misrepresentative of reality, according to a leading non-profit…